Armillaridin induces autophagy-associated cell death in human chronic myelogenous leukemia K562 cells
In conclusion, AM is capable of inhibiting growth and inducing autophagy-associated cell death in K562 cells, but not in normal monocytes. It may have potential to be developed as a novel therapeutic agent against leukemia.
Source: Tumor Biology - Category: Cancer & Oncology Source Type: research
More News: Acute Leukemia | Adenoviruses | Biology | Cancer & Oncology | Chronic Leukemia | Chronic Myeloid Leukaemia | Leukemia